Cancer feature: cnaBLCA18

ADCY7 AKTIP AMFR ARL2BP BBS2 BRD7 C16orf78 C16orf80 C16orf97 CAPNS2 CBLN1 CCDC102A CCDC113 CCDC135 CCL17 CCL22 CDH8 CES1 CES5A CETP CHD9 CIAPIN1 CNEP1R1 CNGB1 CNOT1 COQ9 CPNE2 CSNK2A2 CTD-2600O9.1 CX3CL1 CYLD DOK4 FAM192A FTO GINS3 GNAO1 GOT2 GPR114 GPR56 GPR97 HEATR3 HERPUD1 IRX3 IRX5 IRX6 KATNB1 KIFC3 LPCAT2 MMP15 MMP2 MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT3 MT4 N4BP1 NDRG4 NKD1 NLRC5 NOD2 NUDT21 NUP93 OGFOD1 PAPD5 PLLP POLR2C PRSS54 RBL2 RP11-105C20.2 RP11-324D17.1 RPGRIP1L RSPRY1 SALL1 SETD6 SLC12A3 SLC38A7 SLC6A2 SNX20 TEPP TOX3 USB1 ZNF319 ZNF423

Known Driver Genes: CYLD

Copy number alternation: loss

AGI-5198

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer